Press release
Hearing Loss Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments
Hearing Loss Overview
Hearing loss is the partial or complete loss of hearing in one or both ears, ranging from mild to profound. There are many causes, and it can affect anyone at any age, but it's most common in people older than 60. Hearing loss in older adults is known medically as presbycusis.
"Hearing Loss Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Hearing Loss Market.
The Hearing Loss Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Hearing Loss Pipeline Report: https://www.delveinsight.com/report-store/hearing-loss-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Hearing Loss treatment therapies with a considerable amount of success over the years. Hearing Loss Key players such as - Acousia Therapeutics, Frequency Therapeutics, Acousia Therapeutics, Decibel Therapeutics, Otonomy, Inc., Pipeline Therapeutics, AudioCure Pharma GmbH, Frequency Therapeutics, Sensorion, and others, are developing therapies for the Hearing Loss treatment
• Hearing Loss Emerging therapies such as - ACOU 082, FX-345, ACOU085, DB-020, OTO 413, PIPE 505, AC102, FX-322, SENS-401, and others are expected to have a significant impact on the Hearing Loss market in the coming years.
• SENS-401 has been granted Orphan Drug Designation by the EMA in Europe for the treatment of sudden sensorineural hearing loss, and by the FDA in the U.S. for the prevention of platinum-induced ototoxicity in pediatric population
• In January 2023, Sensorion announces that the first patient has been enrolled in its Phase 2a Proof of Concept clinical trial ofSENS-401 (Arazasetron) in patients suffering from Cisplatin-Induced Ototoxicit
• In February 2023, Frequency Therapeutics, Inc. announced clinical results from the placebo-controlled Phase IIb study of FX-322 in individuals with acquired Sensorineural Hearing Loss (SNHL). Data showed no statistically meaningful difference at day 90 between those administered FX-322 versus those receiving placebo in the proportion of individuals that demonstrated an improvement in speech perception
• In August 2022, Sensorion initiated a Phase II a, open-label, randomized and controlled study investigating repeated twice-daily administration of oral SENS-401 in adult participants with moderately severe to profound hearing loss who have already agreed to undergo cochlear implant surgery justified by their hearing impairment
• In October 2022, Otonomy, Inc., announced that the clinical evaluation of higher doses for OTO-413 (0.75 mg and 1.50 mg) in patients with hearing loss demonstrated no clinically meaningful improvement for patients from baseline across multiple speech-in-noise (SIN) hearing tests
Route of Administration
Hearing Loss pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical
Molecule Type
Products have been categorized under various Molecule types, such as
• Recombinant fusion proteins
• Small molecule
• Monoclonal antibody
• Peptide
• Polymer
• Gene therapy
Hearing Loss Pipeline Therapeutics Assessment
• Hearing Loss Assessment by Product Type
• Hearing Loss By Stage and Product Type
• Hearing Loss Assessment by Route of Administration
• Hearing Loss By Stage and Route of Administration
• Hearing Loss Assessment by Molecule Type
• Hearing Loss by Stage and Molecule Type
DelveInsight's Hearing Loss Report covers around 35+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Emerging Hearing Loss Drugs Under Different Phases of Clinical Development Include:
• ACOU 082: Acousia Therapeutics
• SENS-401: Sensorion
• ACOU085: Acousia Therapeutics
• OTO-413: Otonomy Inc.
• DB-020: Decibel Therapeutics
• FX-345: Frequency Therapeutics
• ACOU085: Acousia Therapeutics
• DB-020: Decibel Therapeutics
• OTO 413: Otonomy, Inc.
• PIPE 505: Pipeline Therapeutics
• AC102: AudioCure Pharma GmbH
• FX-322: Frequency Therapeutics
• SENS-401: Sensorion
Get a Free Sample PDF Report to know more about Hearing Loss Pipeline Therapeutic Assessment
https://www.delveinsight.com/sample-request/hearing-loss-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Hearing Loss Pipeline Analysis:
The Hearing Loss pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Hearing Loss with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Hearing Loss Treatment.
• Hearing Loss key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Hearing Loss Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Hearing Loss market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Further Hearing Loss product details are provided in the report. Download the Hearing Loss pipeline report to learn more about the emerging Hearing Loss therapies
https://www.delveinsight.com/sample-request/hearing-loss-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Hearing Loss Pipeline Market Drivers
• Rapidly growing incidence of acute sensorineural hearing loss
• Rise in geriatric population
Hearing Loss Pipeline Market Barriers
• Challenges associated with the delivery of therapeutics for Sensorineural Hearing Loss
• Poor understanding of the specific underlying pathologies
Scope of Hearing Loss Pipeline Drug Insight
• Coverage: Global
• Key Hearing Loss Companies: Acousia Therapeutics, Frequency Therapeutics, Acousia Therapeutics, Decibel Therapeutics, Otonomy, Inc., Pipeline Therapeutics, AudioCure Pharma GmbH, Frequency Therapeutics, Sensorion, and others
• Key Hearing Loss Therapies: ACOU 082, FX-345, ACOU085, DB-020, OTO 413, PIPE 505, AC102, FX-322, SENS-401, and others
• Hearing Loss Therapeutic Assessment: Hearing Loss current marketed and Hearing Loss emerging therapies
• Hearing Loss Market Dynamics: Hearing Loss market drivers and Hearing Loss market barriers
Request for Sample PDF Report for Hearing Loss Pipeline Assessment and clinical trials
https://www.delveinsight.com/sample-request/hearing-loss-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1 Hearing Loss Report Introduction
2 Hearing Loss Executive Summary
3 Hearing Loss Overview
4 Hearing Loss- Analytical Perspective In-depth Commercial Assessment
5 Hearing Loss Pipeline Therapeutics
6 Hearing Loss Late Stage Products (Phase II/III)
7 Hearing Loss Mid Stage Products (Phase II)
8 Hearing Loss Early Stage Products (Phase I)
9 Hearing Loss Preclinical Stage Products
10 Hearing Loss Therapeutics Assessment
11 Hearing Loss Inactive Products
12 Company-University Collaborations (Licensing/Partnering) Analysis
13 Hearing Loss Key Companies
14 Hearing Loss Key Products
15 Hearing Loss Unmet Needs
16 Hearing Loss Market Drivers and Barriers
17 Hearing Loss Future Perspectives and Conclusion
18 Hearing Loss Analyst Views
19 Appendix
20 About DelveInsight
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF Report to know more about Hearing Loss drugs and therapies https://www.delveinsight.com/sample-request/hearing-loss-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Related Reports-
Hearing Loss Epidemiology https://www.delveinsight.com/report-store/hearing-loss-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Hearing Loss Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Related Reports By DelveInsight -
Hypertrophic Scar Market
https://www.delveinsight.com/report-store/hypertrophic-scar-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Hypertrophic Scar Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hypertrophic Scar, historical and forecasted epidemiology as well as the Hypertrophic Scar market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Lung Fibrosis Market https://www.delveinsight.com/report-store/lung-fibrosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Lung Fibrosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Lung Fibrosis, historical and forecasted epidemiology as well as the Lung Fibrosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Anterior Uveitis Market https://www.delveinsight.com/report-store/anterior-uveitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Anterior Uveitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Anterior Uveitis, historical and forecasted epidemiology as well as the Anterior Uveitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
22q11.2 deletion syndrome Market https://www.delveinsight.com/report-store/22q112-deletion-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "22q11.2 Deletion Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the 22q11.2 Deletion Syndrome, historical and forecasted epidemiology as well as the 22q11.2 Deletion Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
X-Linked Retinitis Pigmentosa (XLRP) Market https://www.delveinsight.com/report-store/x-linked-retinitis-pigmentosa-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "X-Linked Retinitis Pigmentosa Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the X-Linked Retinitis Pigmentosa (XLRP), historical and forecasted epidemiology as well as the X-Linked Retinitis Pigmentosa market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Recent Blog's By DelveInsight:
• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry
https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
Contact Us:
Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187
www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hearing Loss Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments here
News-ID: 2943206 • Views: …
More Releases from DelveInsight Business Research
Spasticity Clinical Pipeline 2025: A Comprehensive Review of 12+ Emerging Therap …
According to DelveInsight's latest analysis, the global Spasticity pipeline features more than 10 active pharmaceutical companies that are advancing over 12 investigational therapies. The report offers a detailed evaluation of clinical trials, mechanisms of action, therapeutic approaches, routes of administration, and major developmental activities shaping the Spasticity treatment landscape.
DelveInsight's report, "Spasticity Pipeline Insight, 2025," delivers an extensive overview of the current clinical development environment and the future outlook for the…
Real-World Evidence Solution Market is set to grow at a 8.07% CAGR, reaching USD …
According to DelveInsight, the real-world evidence (RWE) solutions market is expanding rapidly, primarily due to the increasing global burden of chronic diseases and the growing need to improve healthcare outcomes. In addition, advancements in big data analytics, artificial intelligence, and machine learning are enhancing the ability to efficiently process and interpret large-scale real-world datasets. The rising adoption of RWE solutions by pharmaceutical and biotechnology companies - to support drug development,…
Spinal Implants Market is set to grow at a 5.50% CAGR, reaching USD 21.9 billion …
According to DelveInsight's assessment, the rising burden of spinal disorders particularly within the growing elderly population - continues to significantly increase the demand for surgical correction procedures. Alongside this, the surge in sports-related injuries and trauma cases is accelerating the need for advanced implantable spinal solutions. There is also a notable shift toward non-fusion and motion-preserving devices that support spinal flexibility and enhance patient outcomes, especially for younger and more…
Vascular Stents Market is set to grow at a 6.65% CAGR, reaching USD 18.28 billio …
According to DelveInsight's assessment, the rising global burden of cancer is significantly increasing the demand for advanced treatment approaches such as tumor ablation. Minimally invasive ablation techniques are gaining strong traction due to their advantages, including faster recovery times, lower complication risks, and reduced costs compared with traditional surgical procedures. At the same time, continuous improvements in ablation technologies - particularly in radiofrequency, microwave, and cryoablation systems - have enhanced…
More Releases for Hearing
Atlantic Hearing Care, Inc. Champions Hearing Health with Expert Audiologists & …
Image: https://www.globalnewslines.com/uploads/2025/08/1754924892.jpg
Swampscott & Peabody, MA - Atlantic Hearing Care, Inc., a locally owned, patient-centered leader in audiological services, is proud to reaffirm its unwavering commitment to superior hearing health care. With two convenient locations in Swampscott and Peabody, Massachusetts, the practice continues to elevate community access to comprehensive hearing evaluations, expert audiologist consultations, and a wide array of advanced hearing aids.
As hearing loss affects millions, impacting communication, cognition and emotional…
Audio Help Hearing Centers Elevates Hearing Care with Expert Audiologists and Ad …
Image: https://www.globalnewslines.com/uploads/2025/05/1748357801.jpg
NEW YORK, NY - Audio Help Hearing Centers, a trusted leader in hearing healthcare, continues to set the standard for excellence by offering comprehensive hearing services through its team of expert audiologists. With convenient locations across Chelsea, Columbus Circle, Park Avenue, Scarsdale, and Stamford, Audio Help remains committed to delivering personalized care and the latest in hearing aid technology.
At Audio Help Hearing Centers [https://www.audiohelphearing.com/], patients receive individualized attention from…
Dr George Hearing Centers Expands Hearing Solutions with Custom ITE And Canal He …
Image: https://www.globalnewslines.com/uploads/2025/03/1742895322.jpg
Dr. George Hearing Centers expands its offerings with discreet and high-quality solutions for hearing loss.
Larnaca - March 25, 2025 - Dr. George Hearing Centers recently announced their expansion of innovative hearing solutions with custom In-the-Ear (ITE) and Canal Hearing Aids. This addition to their product lineup reflects the company's endeavour to providing high-quality, personalised hearing care for individuals experiencing hearing loss. The lineup includes Invisible-in-the-canal (IIC), Completely-in-the-canal (CIC), In-the-canal…
Ontario Hearing Centers in Rochester, NY: Delivering Exceptional Hearing Care an …
Image: https://www.globalnewslines.com/uploads/2025/01/1737435436.jpg
Rochester, NY - Ontario Hearing Centers is proud to be a trusted provider of comprehensive hearing care in Rochester, NY. As a locally owned practice with decades of experience, Ontario Hearing Centers continues to set the standard for personalized audiology services and cutting-edge hearing aid technology in the region.
At the heart of Ontario Hearing Centers' success is its commitment to helping individuals improve their quality of life through better…
Global Wireless Hearing Aid Market Driving Future Growth on Wireless Hearing Aid …
Global Wireless Hearing Aid Market 2025:
Global Wireless Hearing Aid Industry Market professional research 2015-2025, is a report which provides the details about industry overview, industry chain, market size (sales, revenue, and growth rate), gross margin, major manufacturers, development trends and forecast.
PDF Copy Available at Disconted Price Check Discount @ https://www.marketgrowthinsight.com/discount/90344
The Global Wireless Hearing Aid Market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of…
Smart Hearing Aids Market Development Insight and Manufacturers Challenges By Ke …
Recent research and the current scenario as well as future market potential of "Global Smart Hearing Aids Market Professional Survey Report 2019".
The Smart Hearing Aids Market comprehensively describes the market and prognosticates it to depict a highly illustrious growth during the forthcoming years. The report offers in-depth analysis of current and future Smart Hearing Aids Market outlook across the globe. The report is projected to help readers with the regions…
